We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VR
1251
DELISTED
Validus Hold Ltd
VR
| $2.5M | 0.01% |
59,280
-1,040
| -2% | -$42.8K |
|
1252
Advanced Micro Devices
AMD
$786B
| $2.48M | 0.01% |
927,042
+54,410
| +6% | +$153K |
|
1253
Copa Holdings
CPA
$6.15B
| $2.48M | 0.01% |
24,601
+840
| +4% | +$91.1K |
|
|
EVHC
1254
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.48M | 0.01% |
21,580
+741
| +4% | +$80.6K |
|
|
AL
1255
DELISTED
Air Lease Corp
AL
| $2.48M | 0.01% |
65,632
+1,165
| +2% | +$42.8K |
|
1256
Mercury Insurance
MCY
$6.07B
| $2.47M | 0.01% |
42,754
+3,020
| +8% | +$170K |
|
1257
Tetra Tech
TTEK
$8.78B
| $2.46M | 0.01% |
512,650
-250
| -0% | -$1.24K |
|
|
BCPC
1258
Balchem Corp
BCPC
$5.7B
| $2.46M | 0.01% |
44,383
-11,425
| -20% | -$654K |
|
|
ANAC
1259
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.46M | 0.01% |
42,462
+4,050
| +11% | +$172K |
|
1260
Myriad Genetics
MYGN
$301M
| $2.45M | 0.01% |
69,243
+1,650
| +2% | +$59.1K |
|
1261
Vishay Intertechnology
VSH
$5.09B
| $2.45M | 0.01% |
177,380
+9,242
| +5% | +$127K |
|
|
SWFT
1262
DELISTED
Swift Transportation Company
SWFT
| $2.45M | 0.01% |
94,095
+19,010
| +25% | +$522K |
|
1263
Synchrony
SYF
$25.8B
| $2.44M | 0.01% |
80,400
+6,250
| +8% | +$195K |
|
1264
Westamerica Bancorp
WABC
$1.38B
| $2.44M | 0.01% |
56,390
+610
| +1% | +$26.6K |
|
1265
KB Home
KBH
$3.61B
| $2.43M | 0.01% |
155,693
+16,050
| +11% | +$224K |
|
1266
Genpact
G
$5.98B
| $2.43M | 0.01% |
104,574
-70
| -0.1% | -$1.51K |
|
|
HDS
1267
DELISTED
HD Supply Holdings, Inc.
HDS
| $2.43M | 0.01% |
78,041
+2,410
| +3% | +$70.1K |
|
|
MRH
1268
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $2.43M | 0.01% |
63,241
-3,600
| -5% | -$130K |
|
|
FNGN
1269
DELISTED
Financial Engines, Inc.
FNGN
| $2.43M | 0.01% |
58,079
+6,450
| +12% | +$254K |
|
1270
Northwest Bancshares
NWBI
$2.34B
| $2.43M | 0.01% |
204,704
+900
| +0.4% | +$10.7K |
|
|
PDM
1271
Piedmont Realty Trust
PDM
$1.21B
| $2.42M | 0.01% |
130,149
+650
| +0.5% | +$12.3K |
|
1272
Acadia Pharmaceuticals
ACAD
$4.93B
| $2.42M | 0.01% |
74,253
+11,685
| +19% | +$402K |
|
|
DWA
1273
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $2.42M | 0.01% |
99,828
+5,194
| +5% | +$110K |
|
|
CHMT
1274
DELISTED
Chemtura Corporation
CHMT
| $2.41M | 0.01% |
88,234
+410
| +0.5% | +$10.1K |
|
|
HTS
1275
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $2.41M | 0.01% |
132,619
+4,825
| +4% | +$87.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.